162 results on '"D'Andrea, Gabriella"'
Search Results
2. Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial.
3. CCR Translation for This Article from HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
4. A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer
5. A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer
6. Pericardiocentesis de emergencia en taponamiento cardíaco
7. Síndrome de Asperger
8. A brief comprehensive overview of surrogacy.
9. Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer
10. Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab as First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer
11. Dynamic Partial Reconfiguration Profitability for Real-Time Systems
12. An Investigation of Dynamic Partial Reconfiguration Offloading in Hard Real-Time Systems
13. Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC).
14. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer
15. Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible
16. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
17. A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma
18. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective
19. A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer
20. Work-In-Progress: Cyber-Physical Systems and Dynamic Partial Reconfiguration Scalability: opportunities and challenges
21. Pericardiocentesis de emergencia en taponamiento cardíaco
22. A Phase I Study of Cetuximab/Paclitaxel in Patients with Advanced-Stage Breast Cancer
23. Design for ReConfigurability: An Electronic System Level Methodology to Exploit Reconfigurable Platforms
24. Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer.
25. Síndrome de Asperger
26. A Phase II Trial of Gemcitabine in Patients with Metastatic Breast Cancer Previously Treated with an Anthracycline and Taxane
27. A Prospective, Longitudinal Study of the Functional Status and Quality of Life of Older Patients with Breast Cancer Receiving Adjuvant Chemotherapy
28. Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study
29. Síndrome de Asperger
30. Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification
31. Self-adaptive loop for CPSs: is the Dynamic Partial Reconfiguration profitable?
32. Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer
33. Use of antioxidants during chemotherapy and radiotherapy should be avoided
34. Erratum to: A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma
35. A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer
36. Abstract 375: Oncologist use and perception of large panel next generation tumor sequencing
37. LPS által előidézett sejtszintű gyulladásos folyamatok és védő hatású anyagok tesztelése IPEC-J2 bélhámsejt modellrendszeren
38. Abstract CT330: Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
39. Abstract PD5-3: Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
40. Abstract P5-19-23: A phase I clinical trial of ganetespib (heat shock protein 90 inhibitor) in combination with paclitaxel and trastuzumab in human epidermal growth factor receptor-2 positive (HER2+) metastatic breast cancer
41. Phase II Study of Paclitaxel Given Once per Week Along With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
42. Phase I trial of daily PI3Kα inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC).
43. A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer.
44. Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC).
45. Monitoring PIK3CA mutant allele fraction (AF) in cell-free DNA (cfDNA) in metastatic breast cancer (MBC) patients treated with PI3Kα–inhibitor plus letrozole (L) or exemestane (E).
46. Breast Implant Foreign Body Reaction Mimicking Breast Cancer Recurrence on FDG PET/CT
47. Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC).
48. Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC).
49. A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC).
50. Tesetaxel: Activity of an oral taxane as first-line treatment in metastatic breast cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.